1134-8046

S1134-80462017000200109

10.20986/resed.2016.3486/2016

00 04 2017

24 2 109 112

2016 16 11 11

1263-77

2008 48

1378-88

2014 82 ^s10 ^s10 10

French Network of Pharmacovigilance Centres 2013 36

55-62

DS5565-A-U201 US Phase II Study Investigators 2014 37

3253-61

DS5565-A-U201 US Phase II Study Investigators 2015

September 2-5, 2015

Vienna, Austria

2014

NCT02318706

2014

NCT02318719

2016 56

67-77

2014

NCT02187471